No evidence Trump’s drug program for terminal patients saved ‘thousands’ of lives

Former President Donald Trump has boasted in recent months about “Right To Try,” a law he signed in 2018. It’s aimed at boosting terminally ill patients’ access to potentially lifesaving medications not yet approved by the Food and Drug Administration.

SCHOTT Pharma plans Initial Public Offering – Biotech Investments

EQS-Media / 06.09.2023 / 07:21 CET/CEST NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED

September 7, 2023

Lyra pauses work on sinusitis drug; Pathos AI licenses a new asset

Plus, news about Convergent Therapeutics, Turnstone Biologics and Sonnet BioTherapeutics: Lyra Therapeutics pauses development of chronic rhinosinusitis drug: The company Sign up to read this

August 16, 2024

Study reveals how neighboring synapses compete for plasticity resources

Nerve cells in the brain receive thousands of synaptic signals via their “antenna”, the so-called dendritic branch.

September 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.